Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Mycotoxin Testing Market by Type (Aflatoxins, Ochratoxin, Fumonisins, Zearalenone), by Technology (Chromatography, Spectroscopy-Based, Immunoassay-Based) and by Sample (Feed, Food): Global Opportunity Analysis and Industry Forecast, 2023-2032

A15653

Pages: NA

Charts: NA

Tables: NA

The mycotoxin testing market is experiencing a significant growth, and will grow considerably in next few years. The mycotoxin testing ensures that the products are carcinogenic-free, and complies with the international regulation standards. Mycotoxins are toxic chemical compounds produced by a fungus, which can lead to various diseases and even death. Cereals and grains are the products that get affected by the fungus, during storage.

Therefore, mycotoxin testing becomes necessary for such products, to eliminate the risk of health hazards.

COVID-19 Impact analysis

  • Because of COVID-19, the demand for advanced technologies, such as chromatography, and spectrometry has seen significant growth, as they provide faster results than traditional methods, with accuracy and adequacy in various markets which includes mycotoxin testing as well. 
  • As it can be witnessed that consumers are becoming more cautious about the food that they are consuming because of spread of COVID-19, many food and feed manufacturers prefer to use techniques that are giving the quick results as compared to the traditional methods, as it consumes more time and labor for the same required result
  • Considering the situation of panic regarding the spread of the virus, results need to be quick to take further actions. So, it has lead chromatography & spectroscopy-based technology to grow and flourish at the fast and high rate and hold the largest share in the mycotoxin testing industry.

Top Impacting Factors

  • The various government and regulatory bodies across the world have made testing of animal feed and food ingredients as mandatory. The regulatory authorities do not approve animal feed for marketing, unless its safety and efficacy are proven. Such measures to prevent potential threats of contamination, chemicals, and toxic presence have been affecting the growth of the mycotoxin testing market to a great extent.
  • The only restraining factor to the growth of the mycotoxin testing market is Lack of food control systems, technology, infrastructure, and resources in developing countries.
  • The another restraining factor to the growth of the Mycotoxin testing Market is inappropriate and inadequate sample standardization.

Market Trends

Immunoassay-based is the rapidly growing mycotoxin testing technology

ELISA (enzyme-linked immunosorbent assay) is one of the most popular and rapidly growing immunologically-based methods that is being utilized in test kits for the analysis of mycotoxins in foods and feeds. ELISA method for detection of mycotoxins has been used by a number of food safety manufacturers and has been available. This method is based on the ability of a specific antibody to distinguish the three-dimensional structure of a specific mycotoxin

Aflatoxin contamination and its detection  

Aflatoxin contamination in the agricultural commodities and products poses a considerable risk to human and livestock health and economic losses. The aflatoxin can cause several health-related conditions, including acute and chronic aflatoxicosis, immune suppression, liver cancer, liver cirrhosis, stunted growth in children, and many others to humans. Aflatoxins can be detected in several crops, especially in maize and groundnuts. 

Key Benefits of the Report

  • This study presents the analytical depiction of the Mycotoxin Testing industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Mycotoxin Testing market share.
  • The current market is quantitatively analyzed to highlight the Mycotoxin Testing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed Mycotoxin Testing market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the Report

  • Who are the leading market players active in the Mycotoxin Testing market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is " Mycotoxin Testing " Market prediction in the future?
  • Which will be the niches at which players profiling with recent advancements should set a presence?
  • What are the driving factors and opportunities in the market?
  • What are the current trends and predicted trends?
  • What are the challenges faced in the " Mycotoxin Testing " Market?

Key Market Segments

  • By Type
    • Aflatoxins
    • Ochratoxin
    • Fumonisins
    • Zearalenone
  • By Technology
    • Chromatography
    • Spectroscopy-Based
    • Immunoassay-Based
  • By Sample
    • Feed
    • Food
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • Mérieux NutriSciences
  • ALS Limited
  • Bureau Veritas
  • SGS
  • Eurofins
  • Neogen
  • Intertek
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MYCOTOXIN TESTING MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Aflatoxins

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Ochratoxin

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Fumonisins

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Zearalenone

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: MYCOTOXIN TESTING MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Chromatography

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Spectroscopy-Based

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Immunoassay-Based

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: MYCOTOXIN TESTING MARKET, BY SAMPLE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Sample

    • 6.2. Feed

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Food

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: MYCOTOXIN TESTING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Technology

      • 7.2.4. Market Size and Forecast, By Sample

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Mycotoxin Testing Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Technology
        • 7.2.6.3. Market Size and Forecast, By Sample
      • 7.2.7. Canada Mycotoxin Testing Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Technology
        • 7.2.7.3. Market Size and Forecast, By Sample
      • 7.2.8. Mexico Mycotoxin Testing Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Technology
        • 7.2.8.3. Market Size and Forecast, By Sample
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Technology

      • 7.3.4. Market Size and Forecast, By Sample

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Mycotoxin Testing Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Technology
        • 7.3.6.3. Market Size and Forecast, By Sample
      • 7.3.7. Germany Mycotoxin Testing Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Technology
        • 7.3.7.3. Market Size and Forecast, By Sample
      • 7.3.8. Italy Mycotoxin Testing Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Technology
        • 7.3.8.3. Market Size and Forecast, By Sample
      • 7.3.9. Spain Mycotoxin Testing Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Technology
        • 7.3.9.3. Market Size and Forecast, By Sample
      • 7.3.10. UK Mycotoxin Testing Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Technology
        • 7.3.10.3. Market Size and Forecast, By Sample
      • 7.3.11. Russia Mycotoxin Testing Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Technology
        • 7.3.11.3. Market Size and Forecast, By Sample
      • 7.3.12. Rest Of Europe Mycotoxin Testing Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Technology
        • 7.3.12.3. Market Size and Forecast, By Sample
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Technology

      • 7.4.4. Market Size and Forecast, By Sample

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Mycotoxin Testing Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Technology
        • 7.4.6.3. Market Size and Forecast, By Sample
      • 7.4.7. Japan Mycotoxin Testing Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Technology
        • 7.4.7.3. Market Size and Forecast, By Sample
      • 7.4.8. India Mycotoxin Testing Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Technology
        • 7.4.8.3. Market Size and Forecast, By Sample
      • 7.4.9. South Korea Mycotoxin Testing Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Technology
        • 7.4.9.3. Market Size and Forecast, By Sample
      • 7.4.10. Australia Mycotoxin Testing Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Technology
        • 7.4.10.3. Market Size and Forecast, By Sample
      • 7.4.11. Thailand Mycotoxin Testing Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Technology
        • 7.4.11.3. Market Size and Forecast, By Sample
      • 7.4.12. Malaysia Mycotoxin Testing Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Technology
        • 7.4.12.3. Market Size and Forecast, By Sample
      • 7.4.13. Indonesia Mycotoxin Testing Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Technology
        • 7.4.13.3. Market Size and Forecast, By Sample
      • 7.4.14. Rest of Asia Pacific Mycotoxin Testing Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Technology
        • 7.4.14.3. Market Size and Forecast, By Sample
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Technology

      • 7.5.4. Market Size and Forecast, By Sample

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Mycotoxin Testing Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Technology
        • 7.5.6.3. Market Size and Forecast, By Sample
      • 7.5.7. South Africa Mycotoxin Testing Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Technology
        • 7.5.7.3. Market Size and Forecast, By Sample
      • 7.5.8. Saudi Arabia Mycotoxin Testing Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Technology
        • 7.5.8.3. Market Size and Forecast, By Sample
      • 7.5.9. UAE Mycotoxin Testing Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Technology
        • 7.5.9.3. Market Size and Forecast, By Sample
      • 7.5.10. Argentina Mycotoxin Testing Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Technology
        • 7.5.10.3. Market Size and Forecast, By Sample
      • 7.5.11. Rest of LAMEA Mycotoxin Testing Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Technology
        • 7.5.11.3. Market Size and Forecast, By Sample
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. SGS

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Bureau Veritas

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Eurofins

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Intertek

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Mérieux NutriSciences

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. ALS Limited

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Neogen

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MYCOTOXIN TESTING MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MYCOTOXIN TESTING MARKET FOR AFLATOXINS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MYCOTOXIN TESTING MARKET FOR OCHRATOXIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MYCOTOXIN TESTING MARKET FOR FUMONISINS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MYCOTOXIN TESTING MARKET FOR ZEARALENONE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MYCOTOXIN TESTING MARKET, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MYCOTOXIN TESTING MARKET FOR CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MYCOTOXIN TESTING MARKET FOR SPECTROSCOPY-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MYCOTOXIN TESTING MARKET FOR IMMUNOASSAY-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MYCOTOXIN TESTING MARKET, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MYCOTOXIN TESTING MARKET FOR FEED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MYCOTOXIN TESTING MARKET FOR FOOD, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MYCOTOXIN TESTING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA MYCOTOXIN TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 18. U.S. MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. U.S. MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 20. U.S. MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 21. CANADA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 23. CANADA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE MYCOTOXIN TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 37. ITALY MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ITALY MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 39. ITALY MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 43. UK MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. UK MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 45. UK MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC MYCOTOXIN TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 56. CHINA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. CHINA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 58. CHINA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 62. INDIA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. INDIA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 64. INDIA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA MYCOTOXIN TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 96. UAE MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 97. UAE MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 98. UAE MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA MYCOTOXIN TESTING, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA MYCOTOXIN TESTING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA MYCOTOXIN TESTING, BY SAMPLE, 2025-2033 ($MILLION)
  • TABLE 105. SGS: KEY EXECUTIVES
  • TABLE 106. SGS: COMPANY SNAPSHOT
  • TABLE 107. SGS: OPERATING SEGMENTS
  • TABLE 108. SGS: PRODUCT PORTFOLIO
  • TABLE 109. SGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. BUREAU VERITAS: KEY EXECUTIVES
  • TABLE 111. BUREAU VERITAS: COMPANY SNAPSHOT
  • TABLE 112. BUREAU VERITAS: OPERATING SEGMENTS
  • TABLE 113. BUREAU VERITAS: PRODUCT PORTFOLIO
  • TABLE 114. BUREAU VERITAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. EUROFINS: KEY EXECUTIVES
  • TABLE 116. EUROFINS: COMPANY SNAPSHOT
  • TABLE 117. EUROFINS: OPERATING SEGMENTS
  • TABLE 118. EUROFINS: PRODUCT PORTFOLIO
  • TABLE 119. EUROFINS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. INTERTEK: KEY EXECUTIVES
  • TABLE 121. INTERTEK: COMPANY SNAPSHOT
  • TABLE 122. INTERTEK: OPERATING SEGMENTS
  • TABLE 123. INTERTEK: PRODUCT PORTFOLIO
  • TABLE 124. INTERTEK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. MéRIEUX NUTRISCIENCES: KEY EXECUTIVES
  • TABLE 126. MéRIEUX NUTRISCIENCES: COMPANY SNAPSHOT
  • TABLE 127. MéRIEUX NUTRISCIENCES: OPERATING SEGMENTS
  • TABLE 128. MéRIEUX NUTRISCIENCES: PRODUCT PORTFOLIO
  • TABLE 129. MéRIEUX NUTRISCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. ALS LIMITED: KEY EXECUTIVES
  • TABLE 131. ALS LIMITED: COMPANY SNAPSHOT
  • TABLE 132. ALS LIMITED: OPERATING SEGMENTS
  • TABLE 133. ALS LIMITED: PRODUCT PORTFOLIO
  • TABLE 134. ALS LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. NEOGEN: KEY EXECUTIVES
  • TABLE 136. NEOGEN: COMPANY SNAPSHOT
  • TABLE 137. NEOGEN: OPERATING SEGMENTS
  • TABLE 138. NEOGEN: PRODUCT PORTFOLIO
  • TABLE 139. NEOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MYCOTOXIN TESTING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MYCOTOXIN TESTING MARKET
  • FIGURE 3. SEGMENTATION MYCOTOXIN TESTING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MYCOTOXIN TESTING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMYCOTOXIN TESTING MARKET
  • FIGURE 11. MYCOTOXIN TESTING MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. MYCOTOXIN TESTING MARKET FOR AFLATOXINS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MYCOTOXIN TESTING MARKET FOR OCHRATOXIN, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MYCOTOXIN TESTING MARKET FOR FUMONISINS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MYCOTOXIN TESTING MARKET FOR ZEARALENONE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MYCOTOXIN TESTING MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 17. MYCOTOXIN TESTING MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MYCOTOXIN TESTING MARKET FOR SPECTROSCOPY-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MYCOTOXIN TESTING MARKET FOR IMMUNOASSAY-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MYCOTOXIN TESTING MARKET SEGMENTATION, BY BY SAMPLE
  • FIGURE 21. MYCOTOXIN TESTING MARKET FOR FEED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. MYCOTOXIN TESTING MARKET FOR FOOD, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: MYCOTOXIN TESTING MARKET
  • FIGURE 29. TOP PLAYER POSITIONING, 2024
  • FIGURE 30. SGS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. SGS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. SGS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. BUREAU VERITAS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. BUREAU VERITAS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. BUREAU VERITAS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. EUROFINS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. EUROFINS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. EUROFINS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. INTERTEK: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. INTERTEK: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. INTERTEK: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. MéRIEUX NUTRISCIENCES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. MéRIEUX NUTRISCIENCES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. MéRIEUX NUTRISCIENCES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. ALS LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. ALS LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. ALS LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. NEOGEN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. NEOGEN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. NEOGEN: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Mycotoxin Testing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue